Una Ryan

Article Abstract:

A profile of Una Ryan, the President and CEO of AVANT Immunotherapeutics and a recipient of the British Empire for contributions to biotech, is presented. Ryan believes that that business barriers need to be eliminated for biotech to accomplish its real mission, which is to save lives, and young companies must be protected from lawsuits to ensure that they do not get slaughtering during clinical trials.

Biography, Biological products industry, Ryan, Una

---

Executive compensation at private biotech companies: Beyond hearsay

Article Abstract:

The results from a nationwide compensation packages offered by life science sector are presented. The researchers from the Harvard Business School has created the annual Compensation and Entrepreneurship Report in Life Sciences that has proved to be a useful resource for boards, venture investors, CEOs compensation committees and human resource professionals at life science companies.

Management Compensation, Executives, Executive compensation

---

Alexis Borisy

Article Abstract:

Alexis Borisy, chief executive officer (CEO) of the biotech firm CombinatoRx in Cambridge, Massachusetts, is taking an unconventional approach to drug development by combining approved drugs in the hope of finding new drugs. CombinatoRx is using genomic data to find receptors that interact with already approved drugs, whereas other companies screen drugs to match a given receptor.

Chief executive officers, CombinatoRx Inc., Borisy, Alexis

Similar abstracts:

• Abstracts: All systems go. Executive compensation at private biotech companies: a competitive environment. Aligning career ladders and the company vision
• Abstracts: The effect of uncertainty and asset co-specialization on governance in biotechnology alliances
• Abstracts: Testing the law of one price in the Chinese wholesale food markets. Do psychological prices contribute to price rigidity? Evidence from German scanner data on food brands
• Abstracts: China syndrome - a regulatory framework in meltdown? Lack of private financing hobbles emerging biotech regions
• Abstracts: Modeling cellular machinery through biological network comparison. Exploiting biological complexity for strain improvement through systems biology

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.